Published in Arch Intern Med on September 01, 1979
Cardiac abnormalities in liver cirrhosis. West J Med (1989) 1.66
Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis. Gut (1986) 1.19
Cardiac and vascular changes in cirrhosis: pathogenic mechanisms. World J Gastroenterol (2006) 1.06
Effects of vasoactive intestinal polypeptide (VIP) on renal function and plasma renin activity in the conscious rabbit. J Physiol (1983) 1.01
Role of the nitric oxide pathway and the endocannabinoid system in neurogenic relaxation of corpus cavernosum from biliary cirrhotic rats. Br J Pharmacol (2007) 0.80
Pathophysiology and epidemiology of portal hypertension. Drugs (1989) 0.76
Gastrointestinal hormones in alcoholic patients with and without liver disease. Ulster Med J (1986) 0.75
Vasoactive intestinal peptide receptors in rat liver after partial hepatectomy. Biochem J (1992) 0.75
The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26
A physical map of 30,000 human genes. Science (1998) 12.43
Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol (2003) 9.10
Replication dynamics of the yeast genome. Science (2001) 7.56
The problem of quality of life in medicine. JAMA (1997) 5.90
Polypeptide with broad biological activity: isolation from small intestine. Science (1970) 4.14
Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant (2006) 3.78
Common VKORC1 and GGCX polymorphisms associated with warfarin dose. Pharmacogenomics J (2005) 3.75
Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. J Hosp Infect (2006) 3.14
Regulation of o(2) concentration in soybean nodules observed by in situ spectroscopic measurement of leghemoglobin oxygenation. Plant Physiol (1988) 2.99
Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. Eur J Biochem (1972) 2.59
Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease. Gut (2001) 2.56
A SNP resource for human chromosome 22: extracting dense clusters of SNPs from the genomic sequence. Genome Res (2001) 2.49
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev (1998) 2.30
Elevated plasma and tissue levels of vasoactive intestinal polypeptide in the watery-diarrhea syndrome due to pancreatic, bronchogenic and other tumors. N Engl J Med (1975) 2.30
Vasoactive intestinal peptide stimulation of adenylate cyclase and active electrolyte secretion in intestinal mucosa. J Clin Invest (1974) 2.28
Overview of the MHC fine mapping data. Diabetes Obes Metab (2009) 2.24
Nitrogenase activity, nodule respiration, and o(2) permeability following detopping of alfalfa and birdsfoot trefoil. Plant Physiol (1992) 2.11
Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis (2001) 2.09
How physically active are South Asians in the United Kingdom? A literature review. J Public Health (Oxf) (2004) 2.09
Vasoactive intestinal peptide: a possible transmitter of nonadrenergic relaxation of guinea pig airways. Science (1980) 2.01
Mechanism of Nitrogenase Inhibition in Soybean Nodules : Pulse-Modulated Spectroscopy Indicates that Nitrogenase Activity Is Limited by O(2). Plant Physiol (1990) 1.97
Information needs of health care professionals in an AIDS outpatient clinic as determined by chart review. J Am Med Inform Assoc (1995) 1.96
VIP as a possible neurotransmitter of non-cholinergic non-adrenergic inhibitory neurones. Nature (1980) 1.87
Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissue. Science (1976) 1.76
Localization of VIP-immunoreactive nerves in airways and pulmonary vessels of dogs, cat, and human subjects. Cell Tissue Res (1981) 1.74
Structure of the porcine vasoactive intestinal octacosapeptide. The amino-acid sequence. Use of kallikrein in its determination. Eur J Biochem (1974) 1.71
Surgical face masks in modern operating rooms--a costly and unnecessary ritual? J Hosp Infect (1991) 1.70
Salary equity among male and female internists in Pennsylvania. Ann Intern Med (2000) 1.69
Biological activities of synthetic peptides corresponding to fragments of and to the entire sequence of the vasoactive intestinal peptide. Proc Natl Acad Sci U S A (1973) 1.67
The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference? BJU Int (2002) 1.65
Familial history of stroke and stroke risk. The Family Heart Study. Stroke (1997) 1.61
The nucleotide sequence of Saccharomyces cerevisiae chromosome XIII. Nature (1997) 1.59
Subcutaneous compared with intravenous epoetin in patients receiving hemodialysis. Department of Veterans Affairs Cooperative Study Group on Erythropoietin in Hemodialysis Patients. N Engl J Med (1998) 1.57
Twenty-year survivors of heart transplantation at Stanford University. Am J Transplant (2008) 1.57
The nucleotide sequence of Saccharomyces cerevisiae chromosome IX. Nature (1997) 1.56
Optimization of techniques in screening CT of the sinuses. AJNR Am J Neuroradiol (1991) 1.56
The undesirable patient. J Chronic Dis (1970) 1.53
Effects on smooth muscle preparations of unidentified vasoactiv peptides from intestine and lung. Nature (1970) 1.51
Complications of acute peritoneal dialysis. J Chronic Dis (1975) 1.46
Probable transmission of Toxoplasma gondii by organ transplantation. Ann Intern Med (1979) 1.46
ST-elevation myocardial infarction following heart transplantation as an unusual presentation of coronary allograft vasculopathy: a case report. Transplant Proc (2013) 1.44
Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam. Infect Immun (1999) 1.36
Release of vasoactive intestinal polypeptide in mast cells by histamine liberators. Nature (1978) 1.35
Potent peripheral and splanchnic vasodilator peptide from normal gut. Nature (1970) 1.30
Renal handling of sodium and water in the hypothyroid rat. Clearance and micropuncture studies. J Clin Invest (1972) 1.28
Null mutation of the Lmo4 gene or a combined null mutation of the Lmo1/Lmo3 genes causes perinatal lethality, and Lmo4 controls neural tube development in mice. Mol Cell Biol (2004) 1.26
Occurrence of vasoactive intestinal polypeptide (VIP)-like immunoreactivity in certain cholinergic neurons of the cat: evidence from combined immunohistochemistry and acetylcholinesterase staining. Neuroscience (1979) 1.23
Hyperglycemic and glycogenolytic effects of vasoactive intestinal polypeptide. Proc Soc Exp Biol Med (1973) 1.22
Platelet-activating factor raises airway and vascular pressures and induces edema in lungs perfused with platelet-free solution. Am Rev Respir Dis (1984) 1.19
Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindred. J Lipid Res (1999) 1.17
Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors. Gene Ther (2009) 1.17
The clinical spectrum of renal vein thrombosis: acute and chronic. Am J Med (1980) 1.16
Vasoactive intestinal polypeptide in brain: localization in and release from isolated nerve terminals. Proc Natl Acad Sci U S A (1977) 1.16
The simultaneous measurement of low rates of CO2 and O2 exchange in biological systems. Anal Biochem (1997) 1.15
The nephrotic syndrome as a complication of gold therapy. Arthritis Rheum (1971) 1.14
Vasoactive intestinal peptide as a neural mediator of gastric relaxation. Am J Physiol (1985) 1.14
Vasoactive intestinal polypoptide: inactivation in liver and potentiation in lung of anesthetized dogs (384699). Proc Soc Exp Biol Med (1975) 1.14
Relationship between blood pH and potassium and phosphorus during acute metabolic acidosis. Am J Physiol (1978) 1.13
Stimulation of insulin and glucagon secretion by vasoactive intestinal peptide. Am J Physiol (1977) 1.13
Enhancement of pulmonary vascular remodelling and inflammatory genes with VIP gene deletion. Eur Respir J (2008) 1.09
Characteristics of interactions between surfactants and the human erythrocyte membrane. Biochim Biophys Acta (1971) 1.08
VIP inhibits basal and histamine-stimulated proliferation of human airway smooth muscle cells. Am J Physiol (1995) 1.07
Vasoactive intestinal polypeptide (VIP): current status. Peptides (1984) 1.06
Effect of VIP infusion in water and ion transport in the human jejunum. Gastroenterology (1980) 1.06
Vasoactive intestinal polypeptide excitation of central neurons. Can J Physiol Pharmacol (1978) 1.06
Clinical heart-lung transplantation. Transplantation (1984) 1.05
Distribution of enteric nerve cell bodies and axons showing immunoreactivity for vasoactive intestinal polypeptide in the guinea-pig intestine. Neuroscience (1980) 1.04
A painful cutaneous nodule as the presentation of metastatic transitional cell carcinoma of the renal pelvis. J Am Acad Dermatol (2000) 1.03
Transplant coronary artery disease: histopathologic correlations with angiographic morphology. J Am Coll Cardiol (1991) 1.02
Early detection of hypersensitivity pneumonitis in office workers. Am J Med (1978) 1.02
Vasoactive intestinal peptide and its relationship to ganglion cell differentiation in neuroblastic tumors. Lab Invest (1979) 1.01
Nephrotic syndrome in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1995) 1.00
Inhibition by vasoactive intestinal peptide of glycoconjugate and lysozyme secretion by human airways in vitro. Am Rev Respir Dis (1981) 0.99
The impact of screening sinus CT on the planning of functional endoscopic sinus surgery. Otolaryngol Head Neck Surg (1991) 0.99
Vasoactive intestinal peptide. J Endocrinol Invest (1986) 0.99
Nitric oxide as a mediator of oxidant lung injury due to paraquat. Proc Natl Acad Sci U S A (1994) 0.99
Metabolic functions of the pulmonary circulation. Circ Res (1982) 0.99
Treatment of fistula-in-ano using a porcine small intestinal submucosa anal fistula plug. Tech Coloproctol (2012) 0.99
Platelet-activating factor increases pulmonary microvascular permeability and induces pulmonary edema. A preliminary report. Bull Eur Physiopathol Respir (1983) 0.98
Hepatitis C infection in two urban hemodialysis units. Kidney Int (1990) 0.98
Risk adjustment: the missing piece of market competition. Health Aff (Millwood) (1996) 0.98
Incomplete syndrome of renal tubular acidosis induced by lithium carbonate. J Lab Clin Med (1975) 0.98
Cervical metastases of head and neck squamous cell carcinoma correlate with loss of heterozygosity on chromosome 16q. Int J Oncol (1999) 0.97
Humoral control of airways. Ann N Y Acad Sci (1974) 0.97
Neuropeptides as regulators of airway function: vasoactive intestinal peptide and the tachykinins. Physiol Rev (1995) 0.97
Isolation of a new naturally occurring halogenated amino acid: monochloromonobromotyrosine. Biochim Biophys Acta (1971) 0.96
Predictors of disease-free survival in rectal cancer patients undergoing curative proctectomy. Colorectal Dis (2008) 0.96
Vasoactive intestinal peptide. Relaxant neurotransmitter in tenia coli of the guinea pig. Gastroenterology (1985) 0.95
Vasoactive intestinal polypeptide (VIP) in mouse and rat brain: an immunocytochemical study. Brain Res (1980) 0.95
Oxygen regulation of a nodule-located carbonic anhydrase in alfalfa. Plant Physiol (2000) 0.95
The 8.5-kb PstI allele of the stress protein gene, Hsp70-2: an independent risk factor for systemic lupus erythematosus in African Americans? Hum Immunol (1996) 0.94
Relationship of spasmogenic and smooth muscle relaxant peptides from normal lung to other vasoactive compounds. Nature (1977) 0.93
Regulation of apoptosis by vasoactive peptides. Am J Physiol Lung Cell Mol Physiol (2001) 0.93
Looking at health from the consumers' point of view. Occup Health (Lond) (1980) 0.93
Reactivity of the human erythrocyte membrane to sodium trinitrobenzenesulphonate. Biochim Biophys Acta (1971) 0.93
Retransplantation for severe accelerated coronary artery disease in heart transplant recipients. Am J Cardiol (1988) 0.93
Pulmonary alveolar hypoxia: release of prostaglandins and other humoral mediators. Science (1974) 0.93